Featured Posts
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly, it…
Blog
More Good News on the Road to Ending the Pandemic
A new study from the Center for Disease Control and Prevention, which shows that a single dose of either the Pfizer-BioNTech or the Moderna…
Blog
Prescription Drug Price Controls are a Trump Legacy Worth Eradicating
During his first month in office, President Biden has seemingly been more interested in eradicating Donald Trump’s legacy than pushing his own proposals, though…
Search Posts
Blog
Trump Administration Expected to Adopt Socialized Medicine Drug Pricing Control Scheme
Regardless of the outcome of the Iowa Caucuses on Monday night, the successive presidential campaigns of Democratic Socialist Senator Bernie Sanders (I-VT) have dragged the…
Fox News
Pelosi, Progressive Caucus Clash over Drug Pricing Legislation
Fox News cites Research Fellow Patrick Hedger on Nancy Pelosi’s proposed “Lower Drug Costs Now Act.” But according to the right-leaning Competitive Enterprise…
News Release
House Bill Setting Price Controls on Medicines Would Endanger Patients, Harm Innovation
House Speaker Nancy Pelosi and Majority Leader Steny Hoyer plan to bring H.R. 3, the Lower Drug Costs Now Act, to the floor for a…
Real Clear Markets
With Drug Pricing, Bipartisanship Isn’t an Excuse to Violate the Laws of Economics
In an age of intense political polarization, some may assume anything that House Speaker Nancy Pelosi and President Donald Trump even marginally agree on has…
The Economic Standard
Drug Reference Pricing Threatens Patient Health, Innovation
The Economic Standard cites Research Fellow Patrick Hedger and CEI’s event on drug reference pricing: Some recent proposals to lower drug prices are…
News Release
Foreign Reference Pricing Schemes Threaten Patient Health and America’s Leadership in Medical Innovation
International policy experts and patients gathered today in Washington, D.C. to discuss the potential impact of foreign reference pricing schemes, which have been proposed by the…